Treatment with apigenin and chrysin reduced liver cancer HepG2 and breast cancer MDA-MB-231 cell viability as well as induced apoptosis via down-regulation of S-phase kinase-associated protein-2 (Skp2) and low-density lipoprotein receptor-related protein 6 (LRP6) expression. Here, LRP6 is linked to breast carcinoma.